Vildagliptin is an oral antidiabetic medication belonging to the DPP-4 inhibitor class, commonly used in the management of type 2 diabetes mellitus. It works by enhancing the body’s natural ability to regulate blood glucose levels through increased insulin secretion and reduced glucagon release. Maintaining the pharmaceutical purity of Vildagliptin is essential to ensure its clinical effectiveness, minimize adverse effects, and meet stringent regulatory standards. Impurity profiling is a crucial step in identifying and controlling unwanted substances that may arise during its manufacturing, storage, or degradation. Here are some of its known impurities listed below.
Showing 1 - 1 of 1 products
